doi: 10.1111/j.2042-7158.1978.tb13171.x.
Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat
- PMID: 24092
- DOI: 10.1111/j.2042-7158.1978.tb13171.x
Item in Clipboard
Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat
J Pharm Pharmacol.
1978 Feb.
Abstract
Arachidonic acid-induced aggregation of rat platelets and the accompanying generation of thromboxane A2 activity were inhibited by aspirin, whereas 20 times higher doses of salicylic, gentisic and salicyluric acids were inactive. Salicylic acid administered to the rats before aspirin prevented the inhibition of the cyclo-oxygenase-mediated effects of arachidonic acid. These results do not support the hypothesis that the anti-inflammatory activity of salicylic acid is due to inhibition of prostaglandin systhetase (cyclo-oxygenase) by an unknown metabolite and indicate that salicylic acid displays an anti-inflammatory activity independent inhibition of prostaglandin biosynthesis.
Similar articles
-
The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines.Eur J Pharmacol. 1978 Aug 1;50(3):231-41. doi: 10.1016/0014-2999(78)90355-2. Eur J Pharmacol. 1978. PMID: 99321
-
Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.Acta Biol Med Ger. 1978;37(5-6):741-2. Acta Biol Med Ger. 1978. PMID: 742286
-
Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.Biomed Biochim Acta. 1984;43(8-9):S389-92. Biomed Biochim Acta. 1984. PMID: 6440555
-
Mechanisms of action: aspirin.Thromb Res Suppl. 1983;4:47-51. doi: 10.1016/0049-3848(83)90357-2. Thromb Res Suppl. 1983. PMID: 6415858 Review.
-
Thromboxane A2 and prostacyclin formation in rats fed cod-liver or sunflower oil.Nutr Rev. 1982 May;40(5):157-9. doi: 10.1111/j.1753-4887.1982.tb05296.x. Nutr Rev. 1982. PMID: 6808427 Review. No abstract available.
Cited by
-
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.Elife. 2016 May 31;5:e11156. doi: 10.7554/eLife.11156. Elife. 2016. PMID: 27244239 Free PMC article.
-
Arachidonate metabolism via lipoxygenase and 12L-hydroperoxy-5,8,10,14-icosatetraenoic acid peroxidase sensitive to anti-inflammatory drugs.Proc Natl Acad Sci U S A. 1980 Jan;77(1):308-12. doi: 10.1073/pnas.77.1.308. Proc Natl Acad Sci U S A. 1980. PMID: 6767237 Free PMC article.
-
Effects of inflammatory agents on endothelial lysosomal fragility and their inhibition by anti-inflammatory drugs.Br J Pharmacol. 1981 Apr;72(4):603-8. doi: 10.1111/j.1476-5381.1981.tb09140.x. Br J Pharmacol. 1981. PMID: 7284680 Free PMC article.
-
Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.Eur J Clin Pharmacol. 1983;25(3):313-7. doi: 10.1007/BF01037940. Eur J Clin Pharmacol. 1983. PMID: 6628518 Clinical Trial.
-
Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.Br J Clin Pharmacol. 1986 Mar;21(3):309-17. doi: 10.1111/j.1365-2125.1986.tb05195.x. Br J Clin Pharmacol. 1986. PMID: 3083851 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
